Categorized | Audio & Video, Featured, QbD News

Allergan CEO: Reform Will Drive Manufacturing, R&D Efficiency

    Allergan CEO:  Reform Will Drive Manufacturing, R&D Efficiency

    In this videotaped interview, Allergan’s CEO David Pyott, discusses the impact of healthcare reform on the industry.  Efficiency, in manufacturing, R&D and other efforts, will be key, he says.  Will the need for efficiency spur interest, and corporate investment, in QbD and PAT?

    Related posts:

    1. Ajaz Hussain on the State of Pharmaceutical Manufacturing
      The progress of Quality by Design and other key industry initiatives is slow, says Ajaz Hussain, CSO at Philip Morris...
    2. Continuous Manufacturing in Pharma: Myths and Missed Opportunities
      Despite many precedents from other industries, pharma resists continuous manufacturing and its financial benefits. Ali Afnan questions why. ...
    3. Merck’s Integrated QbD Approach: Patient-Focused and Bringing Manufacturing Closer to Development
      Merck experts provide a snapshot into their efforts to integrate QbD across different teams and to broaden the role that...
    4. 8 Rules for Moving Drug Manufacturing Forward
      Fast-changing environment + slow-changing species = extinction. To stay competitive, says Claus Weisemann of Grifols Biologicals, manufacturers must heed these...
    5. Continuous Manufacturing in Pharma: Beginning to Snowball?
      At an AAPS 2010 symposium, FDA’s Christine Moore presented the Agency’s (positive) view on continuous manufacturing....

    Leave a Reply

    You must be logged in to post a comment.